[Are there new viewpoints in the treatment of Crohn disease?].
D002986:Clinical Trials as Topic; D003424:Crohn Disease / Q000175:diagnosis / Q000188:drug therapy*; D004311:Double-Blind Method; D004338:Drug Combinations / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005944:Glucosamine / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D008775:Methylprednisolone / Q000627:therapeutic use; D008795:Metronidazole / Q000627:therapeutic use; D012460:Sulfasalazine / Q000627:therapeutic use
D004338:Drug Combinations; D008795:Metronidazole; C028423:Salazopyrine; D012460:Sulfasalazine; D005944:Glucosamine; D008775:Methylprednisolone
Gibt es neue Gesichtspunkte bei der Behandlung des Morbus Crohn?